Northrop Grumman reported third quarter sales of $11.1 billion and adjusted EPS of $7.89, slightly missing the consensus estimate of $11.13 billion on the top line. The miss is immaterial against the company's record $110 billion backlog—a multi-year revenue floor that justifies the upgraded guidance.
Management raised full-year adjusted EPS to $29.35-$29.75 from $28.60-$29.10, a 2.6 percent uplift at the midpoint. The guidance increase reflects confidence in margin expansion and operational execution, not demand assumptions—the backlog already proves those.
Northrop maintained full-year sales guidance at $43.75-$44.25 billion, slightly above the consensus of $44.05 billion. Free cash flow guidance remains $3.10-$3.50 billion, aligned with analyst estimates.
For equity investors, the backlog is the story. At $110 billion against trailing twelve-month revenue of roughly $44 billion, NOC has nearly 2.5 years of contracted revenue visibility. This shields the stock from near-term government budget volatility and Pentagon procurement delays—traditional NOC headwinds. Watch for backlog growth continuing in 2025 as defense budgets remain elevated and geopolitical tensions sustain spending pressure.
